WEI KAO: Open Payments
NPI 1629295571 · RONKONKOMA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,016 in 68 payments from 21 companies in 2025. Trend: 2023 $2,400 · 2024 $1,873 · 2025 $2,016
Food & beverage: $2,016
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $467 |
| Otsuka America Pharmaceutical, Inc. | 6 | $344 |
| Novo Nordisk Inc | 7 | $186 |
| Lilly USA, LLC | 6 | $161 |
| Medtronic, Inc. | 1 | $139 |
| PFIZER INC. | 5 | $103 |
| Amneal Pharmaceuticals LLC | 3 | $75 |
| Ardelyx, Inc. | 3 | $74 |
| ABBVIE INC. | 3 | $73 |
| Axsome Therapeutics, Inc. | 2 | $67 |
Products named: REXULTI, FARXIGA, AIRSUPRA, PERCEPT PC BRAINSENSE, Wegovy, LOKELMA, MOUNJARO, UNITHROID.
Industry payments across NY — which companies pay providers there.
